Development and application of a population pharmacokinetic model repository for caffeine dose tailoring in preterm infants
- 27 August 2024
- journal article
- research article
- Published by Taylor & Francis in Expert Opinion on Drug Metabolism & Toxicology
- Vol. 20 (9) , 923-938
Abstract
Considerable interindividual variability for the pharmacokinetics of caffeine in preterm infants has been demonstrated, emphasizing the importance of personalized dosing. This study aimed to develop and apply a repository of currently published population pharmacokinetic (PopPK) models of caffeine in preterm infants to facilitate model-informed precision dosing (MIPD). Literature search was conducted using PubMed, Embase, Scopus, and Web of Science databases. Relevant publications were screened, and their quality was assessed. PopPK models were reestablished to develop the model repository. Covariate effects were evaluated and the concentration - time profiles were simulated. An online simulation and calculation tool was developed as an instance. Twelve PopPK models were finally included in the repository. Preterm infants' age and body size, especially the postnatal age and current weight, were identified as the most clinically critical covariates. Simulated blood concentration-time profiles across these models were comparable. Caffeine citrate dose regimen should be adjusted according to the age and body size of preterm infants. The developed online tool can be used to facilitate clinical decision making. The firstly developed repository of PopPK models for caffeine in preterm infants has a wide range of potential applications in the MIPD of caffeine.Keywords
Funding Information
- Specially Appointed Medical Expert Project of the Jiangsu Commission of Health (2019)
- Special Fund for Clinical Research of the Wu Jieping Medical Foundation (2020)
- National Natural Science Foundation of China (82171705)
- Scientific Research Support Foundation for Top Young Scholars at the Children’s Hospital of Nanjing Medical University (2020)
This publication has 61 references indexed in Scilit:
- Evaluation of Neonatal and Paediatric Vancomycin Pharmacokinetic Models and the Impact of Maturation and Serum Creatinine Covariates in a Large Multicentre Data SetClinical Pharmacokinetics, 2022
- Data‐driven personalization of a physiologically based pharmacokinetic model for caffeine: A systematic assessmentCPT: Pharmacometrics & Systems Pharmacology, 2021
- Population Pharmacokinetics of Levetiracetam: A Systematic ReviewClinical Pharmacokinetics, 2021
- Therapy for Apnoea of Prematurity: A Retrospective Study on Effects of Standard Dose and Genetic Variability on Clinical Response to Caffeine Citrate in Chinese Preterm InfantsAdvances in Therapy, 2020
- Suggestions for Model‐Informed Precision Dosing to Optimize Neonatal Drug TherapyThe Journal of Clinical Pharmacology, 2018
- Reporting guidelines for population pharmacokinetic analysesThe Journal of Clinical Pharmacology, 2015
- Reporting Guidelines for Clinical Pharmacokinetic Studies: The ClinPK StatementClinical Pharmacokinetics, 2015
- Reporting a Population Pharmacokinetic–Pharmacodynamic Study: A Journal’s PerspectiveClinical Pharmacokinetics, 2013
- Population pharmacokinetics of caffeine in premature neonatesEuropean Journal of Clinical Pharmacology, 1997
- The population pharmacokinetics of theophylline in neonates and young infantsJournal of Pharmacokinetics and Biopharmaceutics, 1989